Provided by Tiger Fintech (Singapore) Pte. Ltd.

NLS Pharmaceutics Ltd.

1.50
+0.03002.04%
Post-market: 1.45-0.0499-3.33%19:18 EDT
Volume:25.49K
Turnover:37.09K
Market Cap:1.76M
PE:-0.23
High:1.50
Open:1.46
Low:1.43
Close:1.47
Loading ...

Kadimastem Shareholders Approved the Merger With NLS Pharmaceutics

THOMSON REUTERS
·
31 Jan

NLS Pharmaceutics Submits Research Abstracts to ASCP 2025

TIPRANKS
·
30 Jan

NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

PR Newswire
·
30 Jan

NLS Pharmaceutics Launches Preclinical Program for Fentanyl Dependence Treatment

TIPRANKS
·
28 Jan

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol Er in the Treatment of Fentanyl Dependence

THOMSON REUTERS
·
28 Jan

Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger With NLS

THOMSON REUTERS
·
16 Jan

NLS Pharmaceutics and Kadimastem Advance Merger Plans with $500,000 Fundraising

TIPRANKS
·
08 Jan

NLS Pharmaceutics Shareholders Approve Meeting Agenda

TIPRANKS
·
08 Jan

NLS Pharmaceutics Shares Rise More Than 50% on Merger Progress

Dow Jones
·
30 Dec 2024

NLS Pharmaceutics and Kadimastem Move Forward with Merger Plans

TIPRANKS
·
30 Dec 2024

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement With the SEC Ahead of Proposed Merger

THOMSON REUTERS
·
30 Dec 2024

NLS Pharmaceutics Calls Extraordinary Meeting for Major Capital Restructuring

TIPRANKS
·
24 Dec 2024

NLS Pharmaceutics- a Request for Pre-Ind Meeting Submitted by Kadimastem and Itolerance to FDA for Itol102

THOMSON REUTERS
·
19 Dec 2024

NLS Pharmaceutics, Kadimastem submit request for FDA pre-IND meeting

TIPRANKS
·
19 Dec 2024

NLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders’ Meeting

TIPRANKS
·
18 Dec 2024

NLS Pharmaceutics expects to close Kadimastem merger by end of January

TipRanks
·
12 Dec 2024

NLS Pharmaceutics Advances DOXA Platform Amid Merger Plans

TIPRANKS
·
12 Dec 2024

NLS Pharmaceutics CEO Issues Letter to Shareholders

ACCESSWIRE
·
11 Dec 2024

NLS Pharmaceutics Offers New Investment Opportunities

TIPRANKS
·
05 Dec 2024

NLS Pharmaceutics Prices Up to $1 Million Private Placement

MT Newswires Live
·
05 Dec 2024